DRUG · Unmapped registry intervention
Fiasp®
Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Fiasp® in Type 1 Diabetes Treatment
NCT03895515
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Fiasp® in Type 1 Diabetes Treatment
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
Fiasp®DRUG
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03895515 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.